tiprankstipranks
Advertisement
Advertisement
WuXi Biologics Sets March 24 Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsWuXi Biologics Sets March 24 Board Meeting to Approve 2025 Annual Results
2M ago
WuXi Biologics’ Substantial Shareholder to Cut Stake via HK$38.52 Block Trade
Premium
Company Announcements
WuXi Biologics’ Substantial Shareholder to Cut Stake via HK$38.52 Block Trade
3M ago
Citigroup-Backed HK$4.00 Cash Offer Launched for Wuxi Biologics Shares at 99% Premium
Premium
Company Announcements
Citigroup-Backed HK$4.00 Cash Offer Launched for Wuxi Biologics Shares at 99% Premium
3M ago
Wuxi Biologics Reports Strong Growth in H1 2025
PremiumCompany AnnouncementsWuxi Biologics Reports Strong Growth in H1 2025
8M ago
WuXi Biologics Reports Robust Financial Growth for H1 2025
Premium
Company Announcements
WuXi Biologics Reports Robust Financial Growth for H1 2025
9M ago
WuXi Biologics Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
WuXi Biologics Schedules Board Meeting to Review Interim Results
9M ago
Wuxi Biologics Announces 2025 Annual General Meeting Agenda
PremiumCompany AnnouncementsWuxi Biologics Announces 2025 Annual General Meeting Agenda
11M ago
WuXi Biologics Announces Hong Kong Address Change and Completes Vaccine Facility Transaction
Premium
Company Announcements
WuXi Biologics Announces Hong Kong Address Change and Completes Vaccine Facility Transaction
1y ago
WuXi Biologics: Strong Growth and Strategic Expansion Drive Buy Rating and Target Price Increase
Premium
Ratings
WuXi Biologics: Strong Growth and Strategic Expansion Drive Buy Rating and Target Price Increase
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100